The extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia

International Journal of Evidence-based Healthcare
Elizabeth E RougheadEllie Rosenfeld

Abstract

To provide an estimate of the numbers of medication errors and adverse drug reactions that occur along a person's journey through their hospital stay in Australia. A search of databases and online resources was undertaken to identify published literature on medication safety in the acute care setting in Australia from 2008 to 2013. Data on the rates of adverse drug reactions and medication errors associated with hospitalization was extracted from the published studies. This evidence was synthesized with evidence from previous reviews of medication safety in the acute care setting in Australia conducted in 2002 and 2008. Findings from the Australian literature across the two previous reviews of medication safety and the present review indicate the proportion of all hospital admissions that are medication-related is between 2 and 3%. Studies assessing medication errors on admission to hospital suggest there may be an overall rate of two errors for every three patients at the time of admission to hospital. Large studies examining the rates of prescribing errors in major Australian teaching hospitals give insight into the rates of prescription error and suggest that prescription error rates of up to one error per patient occur in t...Continue Reading

References

Dec 7, 2002·Quality & Safety in Health Care·B DeanN Barber
Feb 26, 2008·International Journal of Medical Informatics·Joanne L CallenJean McIntosh
Dec 2, 2008·Pharmacy World & Science : PWS·Hayley M VasileffManya T Angley
May 22, 2009·QJM : Monthly Journal of the Association of Physicians·J K Aronson
Jul 15, 2009·British Journal of Clinical Pharmacology·Jeffrey K Aronson
Apr 28, 2010·Archives of Internal Medicine·Johanna I WestbrookRichard O Day
Oct 27, 2010·Applied Nursing Research : ANR·Christine DuffieldKate Aisbett
Mar 24, 2011·British Journal of Clinical Pharmacology·Ian D CoombesCharles Mitchell
Sep 21, 2011·Geriatrics & Gerontology International·Tuck Yean YongCampbell Henry Thompson
May 17, 2012·Clinical Medicine : Journal of the Royal College of Physicians of London·Lorna BartonJosephine S Thomas
Jul 6, 2012·International Journal of Clinical Pharmacology and Therapeutics·Anna J TompsonKenneth Raymond

❮ Previous
Next ❯

Citations

Mar 29, 2018·Health Information Management : Journal of the Health Information Management Association of Australia·Yixin TanMichael I Dorevitch
May 8, 2018·Journal of Clinical Pharmacology·Ar Kar AungLinda Velta Graudins
Nov 6, 2018·Australian Journal of Primary Health·Helen BensonKylie A Williams
Mar 31, 2019·The Medical Journal of Australia·Johanna I Westbrook, Melissa T Baysari
Apr 25, 2019·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Elaine K WalshPatricia M Kearney
Aug 24, 2016·International Journal of Evidence-based Healthcare·Elizabeth E Roughead
Jun 5, 2019·Journal of Advanced Nursing·Tracey BucknallElizabeth Manias
Jun 21, 2017·Nursing & Health Sciences·Brett WilliamsIan Patrick
Dec 14, 2019·Drugs -- Real World Outcomes·Gabriella CaleresÅsa Bondesson
Dec 28, 2019·The Australian Journal of Rural Health·Hanan Khalil, Hilton Gruis
Feb 9, 2018·JBI Database of Systematic Reviews and Implementation Reports·Sonia HinesHanan Khalil
Aug 24, 2017·Nurse Educator·Jill Steiner Sanko, Mary Mckay
Sep 22, 2018·International Journal of Evidence-based Healthcare·Svetla GadzhanovaDaniel O'Connor
Jun 4, 2020·International Journal of Evidence-based Healthcare·Hanan KhalilSonia Hines
Aug 7, 2020·Journal of Clinical Nursing·Alison M HutchinsonTracey K Bucknall
Sep 1, 2020·International Journal of Clinical Pharmacy·Centaine SnoswellMichael Barras
Aug 21, 2019·Frontiers in Neurology·Floris Pieter VlaanderenMarjan J Meinders
Feb 13, 2020·The International Journal of Pharmacy Practice·Cathy GeesonBryony Dean Franklin
Dec 11, 2017·Internal Medicine Journal·Nimmi AthuraliyaJane Robertson
Jan 18, 2018·British Journal of Clinical Pharmacology·Nazanin FalconerNeil Cottrell
Feb 14, 2019·BMC Medical Education·David A NewbyAnthony J Smith
Feb 2, 2018·Therapeutic Advances in Drug Safety·Minh-Nha Rhylie NguyenLuke E Grzeskowiak
Mar 1, 2018·European Journal of Hospital Pharmacy. Science and Practice·Martin L CanningBonnie Tai
Nov 3, 2020·International Journal of Clinical Pharmacy·Shannon FinnMichael Barras
Sep 29, 2020·British Journal of Clinical Pharmacology·Nazanin FalconerNeil Cottrell
Oct 10, 2020·Annual Review of Pharmacology and Toxicology·Adam S DarwichAmin Rostami-Hodjegan
Mar 21, 2021·Holistic Nursing Practice·Connie Lynne Ekkens, Pamela Ann Gordon
Jun 5, 2021·Annals of Saudi Medicine·Maryam Ali AlharaibiTariq M Alhawassi
Jun 23, 2021·BMC Medical Informatics and Decision Making·Michael Patrick O'SheaMichael Barry
Jul 15, 2021·The International Journal of Pharmacy Practice·Gina B McLachlanCatherine Wood
Aug 10, 2021·Therapeutic Advances in Drug Safety·Chariclia ParadissisMichael Barras
Jun 17, 2020·Internal Medicine Journal·Elyssia M BourkeShaun L Greene
Oct 31, 2021·European Journal of Clinical Pharmacology·Lunara Teles SilvaFlavio Marques Lopes
Jan 19, 2022·European Journal of Clinical Pharmacology·Nazanin FalconerNeil Cottrell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.